HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2( ) Tumors
Mikolaj Medon, Eva Vidacs, Stephin J Vervoort, Jason Li, Misty R Jenkins, Kelly M Ramsbottom, Joseph A Trapani, Mark J Smyth, Phillip K Darcy, Peter W Atadja, Michael A Henderson, Ricky W Johnstone, Nicole M Haynes
Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2017
This work was financially supported by Victorian Breast Cancer Research Consortium (R.W. Johnstone, M. Medon, and N. M. Haynes); National Health and Medical Research Council of Australia (NHMRC) and Victorian Cancer Agency (R.W Johnstone); Cancer Council of Victoria (N. M. Haynes and R.W. Johnstone).